V, V., F, Z., P, P., I, P., MA, V., L, C., . . . L, C. (2017). Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: The road to elimination. BMC medicine, 15(1), 217. https://doi.org/10.1186/s12916-017-0979-1
Chicago Style (17th ed.) CitationV, Virlogeux, et al. "Modeling HIV-HCV Coinfection Epidemiology in the Direct-acting Antiviral Era: The Road to Elimination." BMC Medicine 15, no. 1 (2017): 217. https://doi.org/10.1186/s12916-017-0979-1.
MLA (9th ed.) CitationV, Virlogeux, et al. "Modeling HIV-HCV Coinfection Epidemiology in the Direct-acting Antiviral Era: The Road to Elimination." BMC Medicine, vol. 15, no. 1, 2017, p. 217, https://doi.org/10.1186/s12916-017-0979-1.
Warning: These citations may not always be 100% accurate.